Use of <scp>continuous glucose monitoring</scp> and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the <scp>ČENDA</scp> registry

Abstract

A rapid increase in CGM use was reported over the 3 years after general reimbursement. HbA1c was associated with time spent on CGM, a continuing decrease was observed in the >70% category. Reimbursement for CGM likely contributes to the improvement of T1D control at the population level.